A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model

被引:55
|
作者
Suttie, A
Nyska, A
Haseman, JK
Moser, GJ
Hackett, TR
Goldsworthy, TL
机构
[1] Integrated Lab Syst Inc, Res Triangle Pk, NC 27709 USA
[2] NIEHS, Lab Expt Pathol, Res Triangle Pk, NC 27709 USA
[3] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA
关键词
grading; quantitation; histopathology; mouse prostatic cancer; TRAMP;
D O I
10.1080/01926230390173842
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To improve the precision and consistency of experimental results, we have developed a scoring system for proliferative epithelial lesions in the mouse prostate based on histological growth patterns observed in individual lobes. Severity of proliferative lesions was divided into 6 categories; the grade of the most advanced lesion was identified for each lobe and its distribution estimated semiquantitatively. A numerical score combining grade and distribution of the most advanced lesion in each lobe was assigned and termed the "distribution-adjusted lesion grade"; the mean of these scores was calculated for each treatment group. Using this grading scheme, we assessed lesion development in ad libitum-fed and 20%-diet-restricted groups of TRAMP (Transgenic Adenocarcinoma of Mouse Prostate) mice that were started on study at 7 weeks of age and sacrificed when 11 and 20 weeks old. The anterior, dorsal, lateral, and ventral prostate lobes showed clear reductions in lesion severity in diet-restricted TRAMPs at 11 and 20 weeks. This method for scoring the epithelial pathology of the prostate in the TRAMP model with minimal to severe proliferative lesions utilizes the natural history of lesion development for assessing the effects of chemical and dietary interventions.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [41] Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis
    Assenmacher, Charles-Antoine
    Santagostino, Sara F.
    Oyama, Mark A.
    Marine, Jean-Christophe
    Bonvin, Elise
    Radaelli, Enrico
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2021, 69 (03) : 203 - 218
  • [42] Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches
    Kido, Larissa Akemi
    Lamas, Celina de Almeida
    Marostica, Mario Roberto, Jr.
    Alves Cagnon, Valeria Helena
    LIFE SCIENCES, 2019, 217 : 141 - 147
  • [43] Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model
    Wu, GJ
    Fu, PP
    Chiang, CF
    Huss, WJ
    Greenberg, NM
    Wu, MWH
    JOURNAL OF UROLOGY, 2005, 173 (05): : 1778 - 1783
  • [44] Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model
    Vasiliauskas, Juozas
    Nashu, Madison A.
    Pathrose, Peterson
    Starnes, Sandra L.
    Waltz, Susan E.
    ONCOTARGET, 2014, 5 (14) : 5547 - 5558
  • [45] The role of SPARC in the TRAMP model of prostate carcinogenesis and progression
    Said, N.
    Frierson, H. F., Jr.
    Chernauskas, D.
    Conaway, M.
    Motamed, K.
    Theodorescu, D.
    ONCOGENE, 2009, 28 (39) : 3487 - 3498
  • [46] The role of SPARC in the TRAMP model of prostate carcinogenesis and progression
    N Said
    H F Frierson
    D Chernauskas
    M Conaway
    K Motamed
    D Theodorescu
    Oncogene, 2009, 28 : 3487 - 3498
  • [47] The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model
    Kaplan, PJ
    Mohan, S
    Cohen, P
    Foster, BA
    Greenberg, NM
    CANCER RESEARCH, 1999, 59 (09) : 2203 - 2209
  • [48] The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression
    Caporali, A
    Davalli, P
    Astancolle, S
    D'Arca, D
    Brausi, M
    Bettuzzi, S
    Corti, A
    CARCINOGENESIS, 2004, 25 (11) : 2217 - 2224
  • [49] Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model
    Foster, BA
    Gingrich, JR
    Kwon, ED
    Madias, C
    Greenberg, NM
    CANCER RESEARCH, 1997, 57 (16) : 3325 - 3330
  • [50] Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
    Pu, Hong
    Collazo, Joanne
    Jones, Elisabeth
    Gayheart, Dustin
    Sakamoto, Shinichi
    Vogt, Adam
    Mitchell, Bonnie
    Kyprianou, Natasha
    CANCER RESEARCH, 2009, 69 (18) : 7366 - 7374